Tue.Mar 11, 2025

article thumbnail

GlossGenius vs. Vagaro: Best Booking Systems for Estheticians?

Maxine Drake

GlossGenius vs. Vagaro? Choosing the right booking system for your esthetics business can feel overwhelming, but the last thing you need is software that creates more headaches instead of making your life easier. Your Booking System Should Make Your Life Easier, Not Create More Headaches You didnt start your business to play tech support. Yet here you are, frustrated with your client management software, wondering if GlossGenius or Vagaro is the right fit.

article thumbnail

Personalized Photoprotection Based on Patient Factors

Dermatology Times

An expert discusses how dermatologists guide patients in selecting sunscreens based on skin type (fair skin, skin of color, sensitive skin), coexisting conditions, and environmental exposure (blue light, heavy sun). They recommend sun protection factor (SPF) levels and key ingredients and address adherence barriers. Beyond sunscreen, protective clothing, antioxidants, and physical blockers help shield against visible light and infrared radiation.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

New Paradigms for the Treatment of Cutaneous Squamous Cell Carcinoma (cSCC) With Emily S. Ruiz, MD

The Dermatology Digest

Knowledge ofcutaneous squamous cell carcinoma (cSCC)has evolved over the last few decades, and Emily Ruiz, MD, MPH, FAAD, a Dermatologist and Mohs micrographic surgeon at Brigham and Womens Hospital in Boston, and Associate Professor of Dermatology at Harvard Medical School in Boston, MA, shares some of latest developments in prognosticating and treating cSCC.

article thumbnail

Addressing Ongoing Benzoyl Peroxide and Benzene Updates at AAD 2025

Dermatology Times

Christopher Bunick, MD, PhD, discussed how to interpret recent benzene research as clinicians await regulatory guidance for benzoyl peroxide.

68
article thumbnail

Join us at the Sorella Summit!

Skin Inc

Were thrilled to announce that the annual Sorella Summit will be held from September 21 to 24, 2025, at Everline Resort in the beautiful Tahoe National Forest.

52
article thumbnail

Reviewing 3 Key Lebrikizumab Abstracts From AAD 2025

Dermatology Times

Anabela Cardoso, MD, discussed lebrikizumabs efficacy in improving itch, skin pain, sleep disturbance, and long-term management in atopic dermatitis.

More Trending

article thumbnail

Dermatology Times' Weekly Crossword: AAD Annual Meeting Insights Edition

Dermatology Times

Test your knowledge of key words and terms associated with dermatology meeting news from the previous week.

article thumbnail

Primal Therapeutics Spa to Open as Longmont’s First Cannabis Hospitality Spa

Spa Industry Association

Founder Jordan Person Celebrates Over a Decade of Advocacy & Innovation in Cannabis Wellness LONGMONT, CO Primal Therapeutics Spa, a groundbreaking cannabis-infused wellness destination, is set to open in Longmont, Colorado, by summer 2025. This marks a historic moment as one of the first approved cannabis hospitality businesses in the city. The spa is an expansion of Primal Therapeutics, a mobile cannabis spa service that has provided plant-based healing for 11 years. “This is the cu

article thumbnail

Michael Gold, MD: Advances in Acne Treatment and Energy-Based Devices

Dermatology Times

Gold highlighted the growing role of energy-based devices in acne treatment during his AAD session.

article thumbnail

Bridging Generations in Beauty Education

Pivot Point International

Bridging the Generational Divide in Beauty Schools: New Research Explores Challenges and Strategies The beauty, barbering, and wellness industries are experiencing a growing generational divide, with beauty schools at the center of this challenge. Differences in teaching approaches, communication styles, and the use of technology are creating obstacles for administrators, instructors, and students alike.

article thumbnail

Late-Breaking ESK-001 Data from the OLE STRIDE Trial Presented at AAD 2025

Dermatology Times

New results from Alumis show a positive clinical response and safety profile after 52 weeks of treatment for patients with plaque psoriasis.

Safety 41
article thumbnail

Developing Story: L’Oréal SA Issues Recall of Effaclar Duo in the U.S.; New Formulation Coming Soon

The Dermatology Digest

LOreal SA has issued a voluntary recall of all lots of La Roche Posays Effaclar Duo in the U.S. due to concern that benzene is in the product, according to multiple media reports. The independent U.S. Lab Valisure has found high levels of benzene in acne treatments containing benzoyl peroxide (BPO) made by several companies. Last year, Valisure filed a petition with the U.S.

article thumbnail

Top 5 Articles of the Week: March 2-7

Dermatology Times

Explore the top headlines of the week including insights on the environmental impact of conferences, new clinical data, and the shift towards more natural-looking results.

Clinic 41
article thumbnail

Lebrikizumab Shows 3-Year Sustained Efficacy in AD

Dermatology Times

The study found half of the patients receiving once-monthly lebrikizumab achieved complete skin clearance at 3 years, with 87% maintaining near-clearance.

article thumbnail

Day 5 Recap: AAD 2025

Dermatology Times

Catch up on coverage from the final day of the 2025 American Academy of Dermatology Annual Meeting held in Orlando, Florida.

article thumbnail

Impact of Oxidative Stress on Skin Health and the Utility of Antioxidants

Dermatology Times

An expert discusses how oxidative stress accelerates skin aging by damaging cells through free radicals, which form from UV exposure. Antioxidants such as vitamins C and E, niacinamide, and polyphenols counteract this damage. Combining antioxidants with sunscreen enhances protection, reducing free radical formation and optimizing skin health.

article thumbnail

Patient Considerations for Selecting Treatment for a 16-Year-Old Male With Severe Alopecia Areata

Dermatology Times

An expert discusses how treatment for this adolescent boy with severe alopecia areata must balance efficacy with age-appropriate safety, considering psychological impact, growth/development factors, and family preferences while selecting among topical, intralesional, systemic, or emerging biologic options.

article thumbnail

Discussing Efficacy and Safety of JAK Inhibitors With Patients and Caregivers

Dermatology Times

An expert discusses how alopecia areata significantly affects adolescent mental health. Treatment with ritlecitinib requires proper severity assessment via Severity of Alopecia Tool (SALT) score, clear communication of realistic timelines and goals, careful monitoring, and discussion of potential adverse effects. Long-term adherence is crucial for maintaining results.

Safety 36
article thumbnail

InflaRX Presents Efficacy and Safety Data on Vilobelimab at AAD 2025

Dermatology Times

Efficacy, safety, and pharmacokinetic data support the use of vilobelimab in treating pyoderma gangrenosum and hidradenitis suppurativa.

Safety 80
article thumbnail

Icotrokinra Demonstrates Promise in Phase 3 ICONIC-LEAD and ICONIC-ADVANCE for Plaque Psoriasis

Dermatology Times

Johnson & Johnsons JNJ-2113 showed promise for PsO, achieving high skin clearance with a strong safety profile.

Safety 41